Leerink Partnrs Issues Pessimistic Outlook for ISRG Earnings

Intuitive Surgical, Inc. (NASDAQ:ISRG) – Stock analysts at Leerink Partnrs reduced their Q4 2024 earnings per share (EPS) estimates for shares of Intuitive Surgical in a report issued on Monday, November 25th. Leerink Partnrs analyst M. Kratky now forecasts that the medical equipment provider will post earnings per share of $1.34 for the quarter, down from their prior forecast of $1.36. The consensus estimate for Intuitive Surgical’s current full-year earnings is $5.45 per share. Leerink Partnrs also issued estimates for Intuitive Surgical’s FY2025 earnings at $6.02 EPS.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. The business had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%.

A number of other research firms also recently issued reports on ISRG. Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. Raymond James raised their price target on Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a research note on Monday, October 14th. Mizuho lifted their target price on Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. Truist Financial lifted their target price on Intuitive Surgical from $520.00 to $570.00 and gave the company a “buy” rating in a research report on Monday, October 14th. Finally, Citigroup lifted their target price on Intuitive Surgical from $512.00 to $560.00 and gave the company a “buy” rating in a research report on Thursday, August 22nd. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $526.06.

Intuitive Surgical Trading Up 1.0 %

Intuitive Surgical stock opened at $542.10 on Tuesday. The firm has a market cap of $193.09 billion, a price-to-earnings ratio of 87.15, a PEG ratio of 5.39 and a beta of 1.39. Intuitive Surgical has a 12 month low of $304.50 and a 12 month high of $552.00. The stock has a fifty day simple moving average of $506.81 and a two-hundred day simple moving average of $466.29.

Hedge Funds Weigh In On Intuitive Surgical

Several institutional investors have recently modified their holdings of ISRG. Waverly Advisors LLC grew its stake in shares of Intuitive Surgical by 27.1% during the first quarter. Waverly Advisors LLC now owns 2,552 shares of the medical equipment provider’s stock worth $1,018,000 after purchasing an additional 544 shares in the last quarter. Kennedy Capital Management LLC acquired a new position in shares of Intuitive Surgical during the first quarter worth $2,545,000. B. Riley Wealth Advisors Inc. grew its stake in shares of Intuitive Surgical by 26.1% during the first quarter. B. Riley Wealth Advisors Inc. now owns 7,466 shares of the medical equipment provider’s stock worth $2,980,000 after purchasing an additional 1,545 shares in the last quarter. Creekmur Asset Management LLC boosted its stake in Intuitive Surgical by 200.0% in the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 42 shares in the last quarter. Finally, Tidal Investments LLC boosted its stake in Intuitive Surgical by 11.5% in the first quarter. Tidal Investments LLC now owns 16,560 shares of the medical equipment provider’s stock valued at $6,609,000 after acquiring an additional 1,710 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, General Counsel Gary Loeb sold 300 shares of the business’s stock in a transaction that occurred on Monday, September 9th. The stock was sold at an average price of $475.00, for a total value of $142,500.00. Following the sale, the general counsel now owns 1,595 shares of the company’s stock, valued at $757,625. The trade was a 15.83 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Jamie Samath sold 108 shares of the business’s stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total value of $58,542.48. Following the completion of the sale, the chief financial officer now directly owns 8,757 shares in the company, valued at approximately $4,746,819.42. The trade was a 1.22 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 50,647 shares of company stock worth $26,170,907 in the last ninety days. Insiders own 0.80% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.